| Ytd | -9.65% | |
| 1y | -8.08% |
| Open | 12.37 | Prev Close | 12.47 | Low | 12.01 | High | 12.56 | Mkt Cap | 418.09M |
| Vol | 60.83K | Avg Vol | 140.54K | EPS | -0.93 | P/E | N/A | Forward P/E | -1.23 |
| Beta | 0.88 | Short Ratio | 1.35 | Inst. Own | 82.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-22 | 50-d Avg | 12.71 | 200-d Avg | 12.12 | 1yr Est | 25.43 |
BNTC News
AWM Investment Company Inc. acquired a new position in Benitec Biopharma Limited (NASDAQ: BNTC) in t
Top Wall Street analysts changed outlook on top names. See all rating changes on analyst ratings pag
Wedbush analyst Yun Zhong initiates coverage on Benitec Biopharma (NASDAQ:BNTC) with a Outperform
Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.24) per share which beat the analys
Late-breaking abstract for BB-301 presented at the Muscular Dystrophy Association (MDA) Clinical and
Evercore ISI Group analyst Cory Kasimov initiates coverage on Benitec Biopharma (NASDAQ:BNTC) wit
- Interim clinical results for the BB-301 Phase 1b/2a study include 12-month post-treatment follow-u
HAYWARD, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec”
-Interim clinical study results for the BB-301 Phase 1b/2a Treatment Study including 12-month follow
Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-tre
Benitec Biopharma Limited (NASDAQ: BNTC - Get Free Report) Director Suvretta Capital Management, L b
Benitec Biopharma Limited (NASDAQ: BNTC - Get Free Report) Director Suvretta Capital Management, L p
The average of price targets set by Wall Street analysts indicates a potential upside of 83.9% in Be
Benitec Biopharma Limited (NASDAQ: BNTC - Get Free Report) Director Suvretta Capital Management, L b
The mean of analysts' price targets for Benitec Biopharma (BNTC) points to an 87.5% upside in the st
Benitec Biopharma (BNTC) has become technically an oversold stock now, which implies exhaustion of t
– Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration (FDA) re
In the past week or so, beneficial owners Carl Icahn and Mario Gabelli made some big bets in Monro I
HAYWARD, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec”
HAYWARD, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec”
HAYWARD, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec”
Investor webcast to be held on Monday November 3, 2025 at 8:00 am EST Investor webcast to be held on
Benitec Biopharma Limited (NASDAQ: BNTC - Get Free Report) has been assigned an average rating of "M
BPTH: 98% | Bio-Path Holdings shares are trading higher after the company announced the completion o
Gainers Axcella Health Inc. (NASDAQ: AXLA) shares gained 65% to $0.2887 in pre-market trading aft
Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesd
On Wednesday, 155 companies set new 52-week lows.
During Tuesday's trading, 188 companies set new 52-week lows.
On Friday, 73 companies reached new 52-week lows.
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company
On Monday, 413 companies reached new 52-week lows.
During Monday's session, 101 companies made new 52-week lows.
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 12
During Wednesday's trading, 517 companies set new 52-week lows.
On Monday, 429 stocks made new 52-week lows.
During Friday's session, 574 stocks hit new 52-week lows.
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tues
On Tuesday, 126 companies set new 52-week lows.
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Frida
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced
On Wednesday, 297 companies achieved new lows for the year.
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after th
Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after g
Gainers Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after
Wednesday's session saw 51 companies set new 52-week lows.